Literature DB >> 31616971

Pruritus and sleep disturbances in patients with psoriasis.

Tomasz Hawro1, Marlena Hawro1, Anna Zalewska-Janowska2, Karsten Weller1, Martin Metz1, Marcus Maurer3.   

Abstract

Psoriasis is a prevalent skin disease that impairs multiple domains of quality of life (QoL). Pruritus, a common symptom in patients with psoriasis, may directly affect sleep, but studies investigating this are limited. We investigated the relationships between pruritus and sleep in 104 in-patients with psoriasis, who underwent dermatological assessment and completed questionnaires to determine psoriasis severity, pruritus intensity, sleep quality, QoL (skin disease-specific and generic), depressive mood and anxiety. In total, 80% of patients reported pruritus, and 39% had sleep disturbances, most commonly awakenings during sleep (33%) and sleepiness during the daytime (30%). Sleep impairment was more frequent in patients with pruritus, who had more difficulty falling asleep (P = 0.031). Overall, 14% of all patients and 34% of the patients who reported sleep disturbances reported that their sleep problems were caused by pruritus. Patients who reported sleep disturbances had lower generic QoL. Pruritus in patients with psoriasis was frequent and relevant, as evidenced by the higher rate of sleep problems in this patient group, and it was linked to a lower QoL.

Entities:  

Keywords:  Anxiety; Depression; Pruritus; Psoriasis; Quality of life; Sleep

Year:  2019        PMID: 31616971     DOI: 10.1007/s00403-019-01998-7

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  6 in total

Review 1.  New Frontiers in Psoriatic Disease Research, Part II: Comorbidities and Targeted Therapies.

Authors:  Di Yan; Andrew Blauvelt; Amit K Dey; Rachel S Golpanian; Samuel T Hwang; Nehal N Mehta; Bridget Myers; Zhen-Rui Shi; Gil Yosipovitch; Stacie Bell; Wilson Liao
Journal:  J Invest Dermatol       Date:  2021-04-19       Impact factor: 7.590

2.  The Assessment of Risk and Predictors of Sleep Disorders in Patients with Psoriasis-A Questionnaire-Based Cross-Sectional Analysis.

Authors:  Julia Nowowiejska; Anna Baran; Marta Lewoc; Paulina Grabowska; Tomasz W Kaminski; Iwona Flisiak
Journal:  J Clin Med       Date:  2021-02-09       Impact factor: 4.241

Review 3.  Interleukin-31 as a Clinical Target for Pruritus Treatment.

Authors:  Kenji Kabashima; Hiroyuki Irie
Journal:  Front Med (Lausanne)       Date:  2021-02-12

4.  Mast cells and tryptase are linked to itch and disease severity in mycosis fungoides: Results of a pilot study.

Authors:  Dorothea Terhorst-Molawi; Katharina Lohse; Katharina Ginter; Viktoria Puhl; Martin Metz; Man Hu; Marcus Maurer; Sabine Altrichter
Journal:  Front Immunol       Date:  2022-08-10       Impact factor: 8.786

5.  The Impact of Pruritus on the Quality of Life and Sleep Disturbances in Patients Suffering from Different Clinical Variants of Psoriasis.

Authors:  Kamila Jaworecka; Marian Rzepko; Luiza Marek-Józefowicz; Funda Tamer; Aleksandra A Stefaniak; Magdalena Szczegielniak; Joanna Chojnacka-Purpurowicz; Ayla Gulekon; Jacek C Szepietowski; Joanna Narbutt; Agnieszka Owczarczyk-Saczonek; Adam Reich
Journal:  J Clin Med       Date:  2022-09-22       Impact factor: 4.964

6.  Prevalence of Metabolic Syndrome and Its Parameters and Their Correlations With Psoriasis Duration, Severity, and Sleep Quality In Psoriasis Patients: A Cross-Sectional Study.

Authors:  Betul Tas; Vasfiye Kabeloglu
Journal:  Dermatol Pract Concept       Date:  2021-05-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.